Julia Mascherbauer

Julia Mascherbauer

Interventional cardiologist / Cardiologist
University Hospital St. Pölten - St Polten, Austria

Latest contributions

Emerging indications for TAVI in 2025

22 May 2025 – From EuroPCR 2025

Prepare for emerging TAVI indications anticipated in 2025. This session reviews clinical cases including asymptomatic severe aortic stenosis, moderate aortic stenosis with heart failure, and severe aortic regurgitation. It discusses supporting evidence from clinical trials, evolving transcatheter technologies, and practical treatment approaches for these novel indications.

Emerging indications for TAVI in 2025

TAVI and coronary artery disease

22 May 2025 – From EuroPCR 2025

Examine the evolving role of coronary artery disease assessment in TAVI patients. This session compares coronary tomography and angiography for pre-TAVI evaluation, reviews safety and effectiveness of CT angiography-based strategies, and introduces the UNICORN procedure for managing high coronary obstruction risk in complex TAVI scenarios including...

TAVI and coronary artery disease

The Landmark RCT - One-year results

21 May 2025 – From EuroPCR 2025

This session presents a detailed analysis of a landmark randomized controlled trial evaluating the Myval transcatheter aortic valve implantation (TAVI) system among other contemporary transcatheter valves. The discussion centers on one-year clinical outcomes, with a particular focus on women, patients with small aortic annuli, and those...

The Landmark RCT - One-year results

How to handle the most clinically relevant challenges in TAVI

21 May 2025 – From EuroPCR 2025

This session explores some of the most clinically complex scenarios encountered in TAVI practice. Three real-world cases address key challenges such as intervention sequencing and transcatheter valve selection in patients with combined coronary artery disease and severe aortic stenosis. The session also examines coronary obstruction risk assessment and...

How to handle the most clinically relevant challenges in TAVI

Breaking barriers in tricuspid valve repair

25 Nov 2024 – From PCR London Valves 2024

What’s driving the future of transcatheter tricuspid valve repair (TTVR)? Dive into the latest breakthroughs with this video!

Gain insights into real-world outcomes from TTVR registries, uncover key findings from the TriCLASP study, explore how TriClip TEER reshapes the right heart, learn how pulmonary hypertension influences TTVR...

Breaking barriers in tricuspid valve repair

New frontiers in TAVI: have we reached them?

25 Nov 2024 – From PCR London Valves 2024

Discover the latest advancements in TAVI as we look into the results of the EARLY TAVR and RHEIA trials. Explore how these groundbreaking findings may influence clinical practice guidelines and shape the future of TAVI, as well as the remaining unmet clinical needs in TAVI.

New frontiers in TAVI: have we reached them?

Rapid-Fire - Rare and unusual (Part 2)

25 Nov 2024 – From PCR London Valves 2024

Delve into a series of rare and unusual cases selected from the PCR London Valves 2024 Clinical Cases submissions. Explore a wide range of complex interventional scenarios, including edge-to-edge strategy failure, a challenging case of LAA occlusion, a large aortic pseudoaneurysm, and more. This rapid-fire session...

Rapid-Fire - Rare and unusual (Part 2)

Advanced mitral TEER - LIVE case

24 Nov 2024 – From PCR London Valves 2024

Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:

  • A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Advanced mitral TEER - LIVE case

Focus on TAVI in female patients

25 Oct 2024

Didier Tchetche, Sabine Bleiziffer, Philippe Généreux, and Julia Mascherbauer explore the latest evidence about women and aortic stenosis.

TAVI unleashed: optimisation of immediate and long-term outcomes

20 Nov 2023 – From PCR London Valves 2023

Consult this session if you want to gain insights into the effects of paravalvular leak, conduction disturbances, stroke, and permanent pacemaker issues following transcatheter aortic valve implantation. The discussion also delves into the design of transcatheter heart valves and its implications for selecting the initial valve...

TAVI unleashed: optimisation of immediate and long-term outcomes

Valve-in-valve: the journey starts with the first prosthesis

17 May 2022 – From EuroPCR 2022

In this EuroPCR 2022 session featuring Philip Maccarthy, Julia Mascherbauer, Hendrik Treede, Christian Hengstenberg, Radoslaw Parma, and Giuseppe Tarantini, analyze the impact of valve-in-valve interventions on lifetime management, learn about particular clinical considerations and the procedural technique of TAVI-in-TAVI procedures, and appreciate the potential pitfalls of...

Valve-in-valve: the journey starts with the first prosthesis

TAVI in bicuspid aortic valves: optimal technique and procedural refinement

21 Nov 2021 – From PCR London Valves 2021

Framed around a "live-in-a-box" case performed in Toulouse, the core of this session will be on procedural technique: how do you best perform a TAVI to get optimal outcomes in bicuspid anatomy? It will also focus on preprocedural planning, and in particular CT image analysis, and detail...

TAVI in bicuspid aortic valves: optimal technique and procedural refinement